Table 1.
Demographics and overdose history information
| Lifetime overdose category | Total (N = 118) | p value | |||
|---|---|---|---|---|---|
| 0–1 overdoses (N = 33) | 2–5 overdoses (N = 54) | 6+ overdoses (N = 31) | |||
| Chicago community location | < .01 | ||||
| Northwest side | 15 (45.5%) | 31 (57.4%) | 7 (22.6%) | 53 (44.9%) | |
| West side | 18 (54.5%) | 23 (42.6%) | 24 (77.4%) | 65 (55.1%) | |
| Race-ethnicity | 0.20 | ||||
| Black/African American | 3 (9.1%) | 10 (18.5%) | 5 (16.1%) | 18 (15.3%) | |
| White | 18 (54.5%) | 14 (25.9%) | 15 (48.4%) | 47 (39.8%) | |
| Latino | 10 (30.3%) | 23 (42.6%) | 8 (25.8%) | 41 (34.7%) | |
| Other | 1 (3.0%) | 1 (1.9%) | 1 (3.2%) | 3 (2.5%) | |
| Multi-racial/ethnic | 1 (3.0%) | 6 (11.1%) | 2 (6.5%) | 9 (7.6%) | |
| Gender at birth | 0.07 | ||||
| Male | 24 (72.7%) | 37 (68.5%) | 28 (90.3%) | 89 (75.4%) | |
| Female | 9 (27.3%) | 17 (31.5%) | 3 (9.7%) | 29 (24.6%) | |
| Age (years) | 0.43 | ||||
| Mean (SD) | 42.37 (11.58) | 41.35 (9.30) | 39.26 (8.05) | 41.09 (9.69) | |
| Median | 40.2 | 41.5 | 40.5 | 40.5 | |
| Min–max | 23.00–67.70 | 26.60–60.20 | 23.30–56.90 | 23.00–67.70 | |
| Age category | 0.45 | ||||
| 18–29 | 3 (9.1%) | 4 (7.4%) | 2 (6.5%) | 9 (7.6%) | |
| 30–39 | 12 (36.4%) | 19 (35.2%) | 11 (35.5%) | 42 (35.6%) | |
| 40–49 | 9 (27.3%) | 17 (31.5%) | 15 (48.4%) | 41 (34.7%) | |
| 50–59 | 6 (18.2%) | 13 (24.1%) | 3 (9.7%) | 22 (18.6%) | |
| 60 or older | 3 (9.1%) | 1 (1.9%) | 0 (0.0%) | 4 (3.4%) | |
| # Lifetime overdoses | < 0.001 | ||||
| Mean (SD) | 0.45 (0.51) | 3.04 (1.01) | 10.87 (4.94) | 4.37 (4.81) | |
| Median | 0.0 | 3.0 | 10.0 | 3.0 | |
| Min–max | 0.00–1.00 | 2.00–5.00 | 6.00–20.00 | 0.00–20.00 | |
| # Past-year overdoses | < 0.001 | ||||
| Mean (SD) | 0.15 (0.36) | 1.02 (1.21) | 2.32 (2.84) | 1.12 (1.85) | |
| Median | 0.0 | 1.0 | 2.0 | 0.0 | |
| Min–max | 0.00–1.00 | 0.00–5.00 | 0.00–10.00 | 0.00–10.00 | |
| Most recent overdose | < 0.001 | ||||
| Never overdosed | 18 (54.5%) | 0 (0.0%) | 0 (0.0%) | 18 (15.3%) | |
| Past month | 1 (3.0%) | 8 (14.8%) | 7 (22.6%) | 16 (13.6%) | |
| < 6 months | 3 (9.1%) | 15 (27.8%) | 9 (29.0%) | 27 (22.9%) | |
| Between 6 and 12 months | 1 (3.0%) | 6 (11.1%) | 1 (3.2%) | 8 (6.8%) | |
| More than 12 months | 10 (30.3%) | 25 (46.3%) | 14 (45.2%) | 49 (41.5%) | |
| Any past-year OD need ER treatment? | 0.49 | ||||
| No | 3 (60.0%) | 10 (34.5%) | 7 (41.2%) | 20 (39.2%) | |
| Yes | 2 (40.0%) | 19 (65.5%) | 10 (58.8%) | 31 (60.8%) | |
| Missing/NA | 28 | 25 | 14 | 67 | |
| Any past-year OD due to fentanyl? | 1.00 | ||||
| No | 0 (0.0%) | 1 (3.4%) | 0 (0.0%) | 1 (2.1%) | |
| Yes | 5 (100.0%) | 28 (96.6%) | 14 (100.0%) | 47 (97.9%) | |
| Missing/NA | 28 | 25 | 17 | 70 | |
Significance tests for all nominal level variables were calculated Fisher's exact test and F tests based on one-way ANOVAs for all ratio level measures
Tests were run on the complete sample excluding 2 cases with no information for number of lifetime overdoses except for any past-year overdose needing ED treatment and past-year overdose due to fentanyl whereby participants with no past-year overdoses were also excluded